RGRoberto Goya-Maldonado

Roberto Goya-Maldonado

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roberto Goya-Maldonado has a total of 571 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Decomposing neuroanatomical heterogeneity in depression: insights from an ENIGMA major depressive disorder working group study in 5146 individuals

    by Lukas Sempach, Sarah Ulrich, Stéphanie E. E. C. Bauduin, Jochen Bauer, Francesco Benedetti, Klaus Berger, Bianca Besteher, Robin Bülow, Colm G. Connolly, Emmanuelle Corruble, et al.

    The clinical and biological heterogeneity of major depressive disorder (MDD) may reflect the aggregation of different conditions with distinct pathologies under a single diagnostic label. Neuroanatomical heterogeneity in MDD was examined using a harmonized, age- and sex-matched sample from the ENIGMA MDD consortium (N = 5146; age range: 9–82 years; 64% female). Analyses of global neurostrucutral variability revealed greater cortical thickness heterogeneity in MDD compared with healthy controls (Cohen’s d = –0.26). Regionally, increased variability in cortical thickness was most prominent in the cingulate (+6.1 to +6.6% more variation in MDD) and insular (+5.8%) cortices, as well as in the frontal (+5.7 to +6.8%) and temporal (+6.1 to +6.8%) lobes. Heterogeneity in cortical thickness was more pronounced among patients using antidepressant medication (Cohen’s d = –0.39). Patient-specific analyses further showed that individuals with markedly increased cortical thickness variability (th percentile relative to the normative range) exhibited greater depressive symptom severity than those within the normative range (5 th –95 th percentile; Cohen’s d = 0.19–0.36). Overall, the results indicate that neuroanatomical heterogeneity in MDD is primarily expressed in cortical thickness, offering refined insights into the neurobiological complexity of structural alterations associated with depression. These findings could guide future stratification efforts examining whether regionally confined changes in cortical thickness within areas of pronounced variability reflect clinically meaningful patient subgroups.

  • Vertex-wise cortical abnormalities in major depressive disorder from 64 cohorts from the DIRECT and ENIGMA MDD consortia

    by Chao-Gan Yan, Zi-Han Wang, Laura K. M. Han, Nina Alexander, Dag Alnæs, Zeynep Başgöze, Stéphanie E. E. C. Bauduin, Jochen Bauer, Francesco Benedetti, Klaus Berger, et al.


  • Open Access

    Psychotropic medications and their interactions with subcortical brain volume in bipolar disorder: An ENIGMA mega-analysis

    by Sinead King, John O’COnnor, Emma Corley, Giulia Tronchin, Elisa Fontana, Leila Nabulsi, Melody J. Y. Kang, Joaquim Radua, Brian Hallahan, Christoph Abé, et al.

    MRI studies in bipolar disorder (BD) have yielded inconsistent findings, partly due to the varied use of psychotropic medications. This study utilised a mega-analysis approach, accounting for concurrent medication status (syndrome-based and Neuroscience-based Nomenclature (NbN) classifications), in order to assess the association of medication status with subcortical brain volumes in BD. Data from 2,664 BD patients and 4,065 controls (CN) were pooled from 34 research groups as part of the ENIGMA Bipolar Disorder Working Group. Standardized ENIGMA protocols were used to measure subcortical brain volumes. Linear-mixed-effects regression evaluated the association between psychotropic medications and subcortical volumes, and moderation analyses explored interactions. Medication-free patients (n = 410) showed mild ventricular enlargement (d = 0.07) and increased putamen volume (d = 0.06) compared to CN. Patients taking psychotropic medications exhibited smaller subcortical volumes (d = -0.06 to -0.11) and larger ventricles (d = 0.11 to 0.19). Use of antiepileptic and antipsychotic medications was associated with smaller hippocampal and thalamic volumes (d = -0.07 to -0.14), while NbN classification indicated that the categories of ‘valproate’ and ‘dopamine and other monoamine receptor antagonists’ are key variables when considering volume differences between BD and CN. Concurrent lithium use weakened the negative association between antiepileptic use and hippocampal volume (β = 0.19, q = 0.038) in patients. Medication status is associated with altered subcortical brain volumes in BD. The NbN classification provides a useful framework for future studies, emphasizing the need for comprehensive longitudinal research to further unravel complex clinical-pharmacological-neurobiological interactions in BD.


  • Open Access

    Brain morphology mediators of the link between childhood trauma and bipolar disorder: a large-scale international analysis

    by Leonardo Tozzi, Maria R. Dauvermann, Emma Corley, Andrea Fernandes, Melody J. Y. Kang, Yanghee Im, Leila Nabulsi, Roberto Goya-Maldonado, Klaus Berger, Marco Hermesdorf, et al.

    Childhood trauma is a risk factor for bipolar disorder, but the biological mechanisms of this association remain incompletely defined. Gray matter differences observed after trauma exposure overlap with those reported in bipolar disorder, suggesting that the association between childhood trauma and bipolar disorder might be mediated through brain morphology. Our goal was to determine whether cortical thickness, cortical surface or subcortical volume mediate the association between childhood trauma and bipolar disorder. We leveraged a large multi-site dataset from the ENIGMA Bipolar Disorder Working Group, comprising of 1,031 participants with bipolar disorder and 2,221 controls from 19 international cohorts. To identify brain morphology mediators of the association of childhood trauma and bipolar disorder, we used high-dimensional mediation analysis and validated our results using leave-one-site-out cross-validation and permutation testing for significance. Severity of childhood trauma was directly associated with higher likelihood of having a bipolar disorder diagnosis (median coefficient 0.841, 95% CI: [0.834, 0.851], p<0.001). Significant mediators were hippocampal volume (0.004, 95% CI: [0.002, 0.005], p<0.001), medial orbitofrontal gray matter thickness (0.002, 95% CI: [0.002, 0.003], p<0.001), and superior frontal gyrus gray matter thickness (0.002, 95% CI: [0, 0.005], p<0.001). Our results show that the severity of childhood trauma exposure is associated with bipolar disorder diagnosis in part through a smaller hippocampus, thinner cortex in the medial orbitofrontal gyrus and thinner cortex in the superior frontal gyrus. The identification of this mechanistic pathway improves our etiologic understanding of bipolar disorder and could help to identify those at risk and enable the development of new interventions.

  • Open Access

    Regional brain morphology and current antidepressant use: findings from 32 international cohorts from the ENIGMA major depressive disorder working group

    by Chaira Serrarens, Yara J. Toenders, Elena Pozzi, André Aleman, Nina Alexander, Zeynep Başgöze, Vladimir Belov, Klaus Berger, Katharina Brosch, Robin Bülow, et al.

    The understanding of how antidepressant (AD) use is associated with brain structure in individuals with major depressive disorder (MDD) remains incomplete. We aimed to examine the association between AD medication use and brain morphology in relation to age and sex by pooling structural neuroimaging and clinical data from 32 cohorts within the ENIGMA-MDD working group. Interaction effects of group (2076 cases with current AD use (AD), 1495 cases not currently taking AD (nAD) and 5125 healthy controls (HC)) with age and sex, and main effects of group on regional brain structure (cortical surface area and thickness, and subcortical volume) were examined. Additionally, we examined the effect of AD type (SSRI, SNRI or mirtazapine) and duration of use on brain morphology. Younger individuals in the AD group showed lower bilateral middle temporal gyrus thickness compared to nAD and HC, but this was not seen in older individuals (crossover around 50 years). Lower hippocampal volume and thinner inferior temporal gyrus were shown in AD compared to nAD. These effects were independent of group differences in disease-course-related measures, but were driven by depressive symptom severity. Greater bilateral rostral anterior cingulate thickness was found in individuals older than approximately 40 years taking mirtazapine compared to individuals taking SSRIs or SNRIs. Evidence for subtle structural brain differences in temporal and limbic regions in individuals with MDD who currently use AD medication were found compared to those not currently taking AD medication. Future longitudinal studies are needed to determine the causality of these associations.


  • Open Access

    White matter tracts associated with iTBS-induced heart rate deceleration and treatment response in major depressive disorder

    by Jonas Wilkening, Roberto Goya-Maldonado

    Intermittent theta burst stimulation (iTBS) is a well-established treatment for major depressive disorder (MDD), but predicting clinical outcomes remains challenging. Heart rate deceleration induced by iTBS has emerged as a potential biomarker for treatment response, yet the role of white matter (WM) properties in mediating these effects is largely unexplored. In this quadruple-blind, crossover study, we investigated the relationship between WM microstructure, iTBS-driven heart rate modulation, and antidepressant effects. Using correlational tractography, we focused on four major WM tracts—the cingulum, fornix, superior longitudinal fasciculus, and uncinate fasciculus—to examine short-term microstructural changes in relation to therapeutic outcomes. At baseline, findings revealed that fractional anisotropy (FA) in the fornix and right dorsal cingulum was negatively correlated with heart rate deceleration, while radial and mean diffusivity (MD, RD) in the fornix were positively correlated. In the right ventral cingulum, FA showed a positively correlation, while MD and RD were negatively correlated with symptom improvement. Longitudinally, FA increases in the left cingulum were significantly associated with greater symptom alleviation post-treatment. Notably, the correlation between iTBS-induced heart rate modulations and clinical improvement after six weeks, previously demonstrated in this cohort, was identified, while WM microstructural properties in the fornix and cingulum demonstrated predictive value for both heart rate modulation and treatment response. WM changes in the cingulum, evident as early as four weeks, highlight its unique neuroplasticity potential along iTBS intervention. Together, these findings provide novel insights into the structural connectivity patterns influencing iTBS outcomes, offering a novel foundation for more personalized therapeutic strategies in MDD.


  • Open Access

    Heart rate modulation and clinical improvement in major depression: A randomized clinical trial with accelerated intermittent theta burst stimulation

    by Jonas Wilkening, Henrike M. Jungeblut, Ivana Adamovic, Vladimir Belov, Peter Dechent, Lara Eicke, Niels Hansen, Vladislav Kozyrev, Lara E. Marten, Yonca Muschke, et al.

    Intermittent theta burst stimulation (iTBS) is a promising noninvasive treatment for major depressive disorder (MDD), though significant variability exists in patient responses. This quadruple-blind, sham-controlled crossover randomized clinical trial investigated whether clinical improvement was influenced by the spatial selection of stimulation sites or early cardiac rhythm modulations. Seventy-five patients with MDD (33 women) were randomized to either personalized stimulation sites—identified via the strongest negative functional connectivity between the left dorsolateral prefrontal cortex and the default mode network—or fixed stimulation at the F3 position of the 10–20 EEG system. Electrocardiograms throughout stimulation monitored heart rate and its variability, focusing on heartbeat deceleration heart rate (RR) slope and changes in the root mean square of successive differences between heartbeats (RMSSD). Findings demonstrated that a higher RR slope within the first 45 s of stimulation predicted greater clinical improvement at 6 weeks, while a lower RMSSD change during the first 270 s correlated with improvement at 1 week. However, no significant differences in outcomes were observed between personalized and fixed stimulation sites. This study identified a significant relationship between early heart rhythm modulations and the antidepressant effects of accelerated iTBS in MDD. Although the spatial determination of stimulation sites did not enhance clinical improvement, iTBS-induced changes in cardiac rhythm during early sessions may develop into valuable biomarkers for stratifying patients, enabling more personalized and effective treatment strategies in the future.


  • Open Access

    Classification of major depressive disorder using vertex-wise brain sulcal depth, curvature, and thickness with a deep and a shallow learning model

    by Roberto Goya-Maldonado, Tracy Erwin-Grabner, Ling-Li Zeng, Christopher R. K. Ching, Andre Aleman, Alyssa R. Amod, Zeynep Basgoze, Francesco Benedetti, Bianca Besteher, Katharina Brosch, et al.

    Major depressive disorder (MDD) is a complex psychiatric disorder that affects the lives of hundreds of millions of individuals around the globe. Even today, researchers debate if morphological alterations in the brain are linked to MDD, likely due to the heterogeneity of this disorder. The application of deep learning tools to neuroimaging data, capable of capturing complex non-linear patterns, has the potential to provide diagnostic and predictive biomarkers for MDD. However, previous attempts to demarcate MDD patients and healthy controls (HC) based on segmented cortical features via linear machine learning approaches have reported low accuracies. In this study, we used globally representative data from the ENIGMA-MDD working group containing 7012 participants from 31 sites (N = 2772 MDD and N = 4240 HC), which allows a comprehensive analysis with generalizable results. Based on the hypothesis that integration of vertex-wise cortical features can improve classification performance, we evaluated the classification of a DenseNet and a Support Vector Machine (SVM), with the expectation that the former would outperform the latter. As we analyzed a multi-site sample, we additionally applied the ComBat harmonization tool to remove potential nuisance effects of site. We found that both classifiers exhibited close to chance performance (balanced accuracy DenseNet: 51%; SVM: 53%), when estimated on unseen sites. Slightly higher classification performance (balanced accuracy DenseNet: 58%; SVM: 55%) was found when the cross-validation folds contained subjects from all sites, indicating site effect. In conclusion, the integration of vertex-wise morphometric features and the use of the non-linear classifier did not lead to the differentiability between MDD and HC. Our results support the notion that MDD classification on this combination of features and classifiers is unfeasible. Future studies are needed to determine whether more sophisticated integration of information from other MRI modalities such as fMRI and DWI will lead to a higher performance in this diagnostic task.


  • Open Access

    Baseline White Blood Cell as a Moderator of Heart-Brain Coupling-Related Response in Depression

    by Bruno Pedraz-Petrozzi, Jonas Wilkening, Alexander Sartorius, Martijn Arns, Roberto Goya-Maldonado

    Background: Low-grade inflammation occurs in ∼30% of individuals with major depressive disorder (MDD) and is linked to poorer treatment outcomes, autonomic dysregulation, and elevated cardiometabolic risk. Such inflammation may contribute to variability in response to intermittent theta burst stimulation (iTBS) of the left dorsolateral prefrontal cortex. We tested whether baseline inflammation moderates the association between heart–brain coupling (HBC) during iTBS and clinical improvement, and examined neuroimaging correlates of inflammatory status. Methods: Inflammation was indexed using routine clinical markers: white blood cell count (WBC) and C-reactive protein (CRP). HBC, a physiological marker of frontal-vagal engagement, was derived from electrocardiographic recordings obtained during the first iTBS sessions. Diffusion MRI free-water metrics were used to assess white-matter microstructural alterations associated with inflammation. Results: Higher HBC was associated with symptom improvement only among individuals with lower WBC. Patients with higher WBC counts showed elevated free-water diffusion MRI signal in the fornix and corpus callosum, suggesting possible inflammation-related white matter differences warranting replication. Conclusions: Baseline WBC moderated the association between HBC and clinical response and may contribute to inter-individual variability in iTBS outcomes. Routine inflammatory markers could support stratification approaches for biomarker-guided neuromodulation in MDD. HIGHLIGHTS: Baseline WBC moderates HBC–iTBS response in major depression High HBC was associated with improvement primarily at lower WBC levels (≈<6.44×10□/L) CRP does not significantly moderate HBC–response associations Exploratory DTI analyses linked higher WBC to increased free-water in the fornix & corpus callosum WBC may be a candidate low-cost stratification marker for future biomarker-guided neuromodulation studies.

  • Open Access

    Long-term retrieval performance is associated with CA1 hippocampal volume in older adults and individuals at risk for dementia

    by Claudia Bartels, Joy Tzu-Yueh Chen, Michael Belz, Renat Yakupov, Emrah Düzel, Wenzel Glanz, Falk Lüsebrink, Peter Dechent, Luca Kleineidam, Melina Stark, et al.

    Background: Long-term retrieval (LTR) and accelerated long-term forgetting (ALF) paradigms might help differentiating individuals at increased dementia risk from healthy controls (HC). Objective: We investigated the utility of a LTR paradigm in discriminating subjective cognitive decline (SCD) from HC and its relationship to the CA1 body volume, a hippocampal structure pivotal to the memory circuitry. Methods: LTR was assessed via recall rates of the ADAS-cog word list and the FCSRT-IR free recall in 59 DELCODE study participants, including individuals with SCD and mild cognitive impairment (MCI), as well as HC, all of them DELCODE study participants. LTR performance was compared between groups and its discriminability between SCD and HC was assessed using ROC curve analysis. 32 SCD and HC participants had FreeSurfer-segmented MRI data, and hippocampal subfield volumes were correlated with LTR rates. Results: Only FCSRT-IR LTR rates sufficiently differentiated SCD from HC (AUC of 0.701; 95% CI 0.537–0.865). Moderate associations of the FCSRT-IR LTR rate with CA1 bodies in both hemispheres (left CA1 body r = 0.419, p = 0.017; right: r = 0.412, p = 0.019), in addition to the left C3 body were observed (r = 0.525, p = 0.002). Conclusions: LTR may constitute a potential indicator of memory circuitry integrity in older adults, which is also mirrored by its association with CA1 volume. Thus, assessment of LTR and associated neural circuits may help to better identify individuals at risk for future cognitive decline today indistinguishable from HC, ultimately paving the way for early intervention.